AIF1 and Huntington disease: However, in all HD patients, including motor, emotional, or mixed symptoms, neither the number of Iba1 (+) cells nor HLA-DP/DQ/DR immunoreactivity, a marker of microglial activation, showed significant changes in this region [39].